Onconova Therapeutics Inc. To Host Webcast Regarding Insights Into Rigosertib Mechanism Of Action With Scientific Founder, Dr. E. Premkumar Reddy
NEWTOWN, Pa., Jan. 17, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it will webcast a presentation by Dr. E. Premkumar Reddy of recent studies regarding the mechanism of action for rigosertib. The webcast will take place on Friday, January 24th at 11:00 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.